Ontology highlight
ABSTRACT:
INSTRUMENT(S): Q Exactive
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Sw-480 Cell, Colon Epithelial Cell, Colon
DISEASE(S): Colon Cancer
SUBMITTER: Christopher Gerner
LAB HEAD: Christopher Gerner
PROVIDER: PXD004789 | Pride | 2022-02-24
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
SW480_cyt_As2O3_1a.mgf | Mgf | |||
SW480_cyt_As2O3_1a.mzid.gz | Mzid | |||
SW480_cyt_As2O3_1a.pride.mgf.gz | Mgf | |||
SW480_cyt_As2O3_1a.pride.mztab.gz | Mztab | |||
SW480_cyt_As2O3_1a.raw | Raw |
Items per page: 5 1 - 5 of 30 |
Kreutz Dominique D Bileck Andrea A Plessl Kerstin K Wolrab Denise D Groessl Michael M Keppler Bernhard K BK Meier Samuel M SM Gerner Christopher C
Chemistry (Weinheim an der Bergstrasse, Germany) 20170110 8
Response profiling using shotgun proteomics for establishing global metallodrug mechanisms of action in two colon carcinoma cell lines, HCT116 and SW480, has been applied and evaluated with the clinically approved arsenic trioxide. Surprisingly, the complete established mechanism of action of arsenic trioxide was observed by protein regulations in SW480, but not HCT116 cells. Comparing the basal protein expression in the two cell lines revealed an 80 % convergence of protein identification, but ...[more]